Ether

Ether

SCHEMBL4940983

C=C(C)C.CCOCC.OCCO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
THRB P10828 1/20 0.39
TSHR P16473 4/20 0.35
LMNA P02545 1/20 0.30
HSD17B10 Q99714 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL15710162 0.92 ALDH1A1 (0.43) ALDH1A1THRBTSHR
Ether SCHEMBL4622027 0.90
Ether SCHEMBL23063642 0.88 ALDH1A1 (0.46) ALDH1A1THRBTSHRHSD17B10
Ether SCHEMBL1173072 0.87 ALDH1A1 (0.56) ALDH1A1THRBTSHRMAPK1
Ether SCHEMBL5575028 0.87 ALDH1A1 (0.56) ALDH1A1THRBTSHRMAPK1
Ether SCHEMBL9639185 0.87 ALDH1A1 (0.56) ALDH1A1THRBTSHRMAPK1
Ether SCHEMBL23356828 0.87 ALDH1A1 (0.56) ALDH1A1THRBTSHRMAPK1
Ether SCHEMBL15741360 0.87 ALDH1A1 (0.56) ALDH1A1THRBTSHRMAPK1
Ether SCHEMBL1419841 0.87 ALDH1A1 (0.56) ALDH1A1THRBTSHRMAPK1
Ether SCHEMBL2582269 0.87 ALDH1A1 (0.56) ALDH1A1THRBTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117946149-A Beta-alkyl substituted silane compound, preparation method and application thereof 武汉大学 2024-04-30 CN claimed
CN-114456134-B Alpha-fluoroalkyl substituted cyclopropyl alcohol compound, and preparation method and application thereof 武汉大学 2024-04-26 CN claimed
CN-117362358-A Planar chiral iodo-metallocene, preparation method thereof and method for preparing polysubstituted planar chiral metallocene compound 武汉大学 2024-01-09 CN disclosed
CN-113383000-A Adducts of triphenylphosphine and triphenyl phosphite and their use in bromination of primary alcohols 法国梅尔基奥材料与生命科学公司 2021-09-10 CN disclosed
CN-111606950-A Method for synthesizing silicon-based phosphorus cluster compound and product thereof 杭州师范大学 2020-09-01 CN disclosed
US-20080114041-A1 Benzothiazolesulfonamides ASTRAZENECA AB (SE) 2008-05-15 US disclosed
EP-1833808-A1 NEW BENZOTHIAZOLESULFONAMIDES AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006068593-A1 NEW BENZOTHIAZOLESULFONAMIDES ASTRAZENECA AB (SE) 2006-06-29 WO disclosed
US-5866705-A PYROPOLYMERIC CERAMIC BAYER AKTIENGESELLSCHAFT (DE) 1999-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114041-A1 Benzothiazolesulfonamides SULT1E1, TST, SULT1A1 ALDH1A1 382/4885THRB 2334/4885TSHR 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.